Peptide Therapeutics Market - Global Industry Analysis
Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024
Published Date: 18-Oct-2018Healthcare
Category: Report Format : PDF
Report Code: ZMR-3439
Status : Published
Global peptide therapeutics market expected to generate revenue of around USD 43.26 billion by the end of 2024, growing at a CAGR of around 9.41% between 2018 and 2024. The peptide is a type of selective signaling molecule which binds to the cell-specific surface receptors or ion channels which helps to trigger the response for different functions of the cell for specific diseases.